04/17/2024
6:07 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
6:07 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
6:08 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2024
4:00 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
5:19 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:20 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
5:17 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/05/2024
4:58 PM | Iovance Biotherapeutics (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:50 PM | Countouriotis Athena (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:51 PM | Bellemin Jean-Marc (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:52 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
7:00 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/01/2024
6:09 PM | Iovance Biotherapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
02/29/2024
6:30 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
3:05 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
3:44 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
02/20/2024
6:52 PM | Iovance Biotherapeutics (Issuer)
MCPEAK MERRILL A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/20/2024
4:23 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/20/2024
5:03 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
5:16 AM | Iovance Biotherapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G/A | |
02/09/2024
4:40 PM | Iovance Biotherapeutics (Subject)
MHR FUND MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
01/25/2024
9:49 AM | Iovance Biotherapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/18/2024
5:07 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:09 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/18/2024
5:09 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
4:03 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
4:00 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/27/2023
3:24 PM | Iovance Biotherapeutics (Subject)
Quogue Capital LLC (Filed by)
| Form SC 13D/A | |
10/18/2023
7:03 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
7:04 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/18/2023
7:05 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/19/2023
3:30 PM | Iovance Biotherapeutics (Issuer)
MCPEAK MERRILL A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
5:12 PM | Iovance Biotherapeutics (Issuer)
Rothbaum Wayne P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
7:17 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2023
4:16 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
4:15 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/17/2023
5:21 PM | BILINSKY IGOR (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
5:22 PM | GRAF FINCKENSTEIN FRIEDRICH (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2023
5:22 PM | Iovance Biotherapeutics (Issuer)
Vogt Frederick G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/13/2023
3:31 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
The "Smart Money" Is Ready for May 1st Are You? (Ad) Former Wall Street VP: "Buy This Stock Now"
Five of America's Most Successful Investors Bought Shares in The Same Company.  One Former Wall St. Trader Explains Why… |
07/11/2023
4:08 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
07/11/2023
3:55 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
4:27 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
07/10/2023
3:40 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/10/2023
7:53 AM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
3:51 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
3:39 PM | Iovance Biotherapeutics (Filer)
| Form 424B5 | |
06/16/2023
3:11 PM | Iovance Biotherapeutics (Filer)
| Form S-3ASR | |
06/08/2023
5:20 PM | Iovance Biotherapeutics (Issuer)
YARNO WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:20 PM | Dukes Iain D. (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:21 PM | Iovance Biotherapeutics (Issuer)
WEISER MICHAEL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:21 PM | Iovance Biotherapeutics (Issuer)
Maynard Ryan D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:21 PM | Iovance Biotherapeutics (Issuer)
MCPEAK MERRILL A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:22 PM | Countouriotis Athena (Reporting)
Iovance Biotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
4:17 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
3:30 PM | Iovance Biotherapeutics (Filer)
| Form 8-K/A | |
05/26/2023
7:38 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/18/2023
3:30 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/10/2023
3:30 PM | Iovance Biotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/27/2023
4:15 PM | Iovance Biotherapeutics (Filer)
| Form ARS | |
04/26/2023
4:15 PM | Iovance Biotherapeutics (Filer)
| Form DEF 14A | |
04/26/2023
4:16 PM | Iovance Biotherapeutics (Filer)
| Form DEFA14A | |
04/24/2023
3:51 PM | Iovance Biotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
